We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPRA
13651
PUT
Opera Ltd
OPRA
$1.8B
-27,000
Closed -$160K
OPRX icon
13652
OptimizeRx
OPRX
$165M
-52,488
Closed -$1.56M
OPTN
13653
PUT
DELISTED
OptiNose
OPTN
-667
Closed -$25K
OPTT icon
13654
CALL
Ocean Power Technologies
OPTT
$55.4M
-23,800
Closed -$34K
OPTT icon
13655
Ocean Power Technologies
OPTT
$55.4M
-24,643
Closed -$35K
OPY icon
13656
Oppenheimer Holdings
OPY
$1.23B
-28,277
Closed -$971K
OPY icon
13657
PUT
Oppenheimer Holdings
OPY
$1.23B
-12,700
Closed -$553K
ORC
13658
CALL
Orchid Island Capital
ORC
$1.32B
-2,160
Closed -$35K
ORLA
13659
DELISTED
Orla Mining
ORLA
-37,269
Closed -$153K
ORLA
13660
PUT
DELISTED
Orla Mining
ORLA
-19,100
Closed -$91K
ORMP icon
13661
PUT
Oramed Pharmaceuticals
ORMP
$178M
-12,600
Closed -$109K
ORN icon
13662
Orion Group Holdings
ORN
$392M
-18,944
Closed -$47K
OSS icon
13663
PUT
One Stop Systems
OSS
$327M
-17,200
Closed -$66K
OTEX icon
13664
PUT
Open Text
OTEX
$6.02B
-12,700
Closed -$538K
OTRK
13665
PUT
DELISTED
Ontrak
OTRK
-526
Closed -$107K
OUNZ icon
13666
VanEck Merk Gold Trust
OUNZ
$2.69B
-20,000
Closed -$377K
OTTR icon
13667
Otter Tail
OTTR
$3.87B
-8,159
Closed -$519K
OUST icon
13668
PUT
Ouster
OUST
$3.25B
-1,670
Closed -$75K
OVID icon
13669
Ovid Therapeutics
OVID
$523M
-38,265
Closed -$92.5K
OWLT icon
13670
PUT
Owlet
OWLT
$182M
-1,050
Closed -$65K
OXLC
13671
Oxford Lane Capital
OXLC
$950M
-28,960
Closed -$1.05M
OXSQ icon
13672
Oxford Square Capital
OXSQ
$160M
-18,361
Closed -$77K
PALI icon
13673
Palisade Bio
PALI
$375M
-93
Closed -$74K
PARAA
13674
CALL
DELISTED
Paramount Global Class A
PARAA
-6,900
Closed -$279K
PARAA
13675
PUT
DELISTED
Paramount Global Class A
PARAA
-5,800
Closed -$234K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.